• xxx

2020 Virtual UK Oncology Forum Programme


UK ONCOLOGY FORUM 2020
Location: VIRTUAL

The UKOF2020 Education Programme will be available in an all-virtual format –videos, slides, and meeting materials, scheduled broadcast sessions, virtual networking and exhibits.

The virtual programme has been designed and developed solely by the UK Oncology Forum Faculty. No sponsors have had any input or influence over the programme design or speaker choices.
This meeting is for UK Oncology Healthcare Professionals only.

The meeting will run strictly in accordance with the ABPI Code of Practice. The varying sponsorships packages are primarily for the purchase of promotional virtual exhibition space.
This meeting is CME accredited.

VIRTUAL EXHIBITION SPACE

The UK Oncology Forum Faculty would like to thank all the sponsors and exhibitors and encourage all attendees to please visit the virtual exhibition area to meet our colleagues from industry.

PART ONE

CCA-UK Workshop (ALL HCPs WELCOME)
Read more
ACP AGM (MEMBERS ONLY)
BOPA (INVITATION ONLY)
NOTCH AGM (ALL HCPs WELCOME)
UKONS MDT Reform Strategy into Practice (ALL HCPs WELCOME)
UKOMiC Committee Meeting (MEMBERS ONLY)
Merck/Pfizer IO-TKI Symposium (ALL HCPs WELCOME)
BAVENCIO® (avelumab) + axitinib for advanced RCC

CHAIR: Dr Sarah Rudman, Guy’s and St. Thomas’ NHS Foundation Trust London
Dr Richard Griffiths, The Clatterbridge Cancer Centre Wirral
Dr Robert Stevenson, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust Birmingham

*Details of the programme attached with prescribing information & adverse event reporting included. This promotional meeting is organised and funded by Merck Serono Ltd on behalf of the Merck-Pfizer alliance and may include reference to Merck and Pfizer medicines relevant to the agenda topics. RCC, renal cell carcinoma. CDF, Cancer Drugs Fund. The UK Oncology Forum Faculty have had no influence or input into the programme or speaker choices
CME is not awarded for commercial symposia
BCTRCG (ALL HCPs WELCOME)
- BCTRCG: Introduction and update on progress
- PEAR: Current UK Practice for the Management of Pregnancy-Associated Breast Cancer
- ALTRA: A national retrospective Audit on Long term TRAstuzumab use in metastatic breast cancer
- PRIMROSE: A national prospective observational study in breast cancer patients with central nervous system involvement in the UK
- Q&A/Open discussion
*PLATINUM SPONSOR - Novartis BREAST Symposium (ALL HCPs WELCOME)
CHAIR: Prof Samreen Ahmed, Consultant Medical Oncologist, University Hospitals of Leicester NHS Trust

- Opening and introduction (Prof Samreen Ahmed)
- PIK3CA mutation and the importance of testing (Dr Philippe Taniere)
- Piqray + fulvestrant: Learnings from SOLAR-1 (Prof Andrew Wardley)
- Safety and how to manage your patients taking Piqray + fulvestrant (Prof Samreen Ahmed)
- Live Q&A session and close (All)
CME is not awarded for commercial symposia
Exhibition & Charity Corner (PLEASE VISIT THE VIRTUAL STANDS)
Welcome & Introduction, Professor Ruth Plummer
Keynote 1 – Professor Gillian Griffiths, Cambridge
Exhibition & Charity Corner

PART TWO

*Bayer Symposium (ALL HCPs welcome)
’Precision oncology and NTRK inhibitors – the histology independent approach to finding and treating patients?’

FACULTY
Dr Alastair Greystoke (Chair), Newcastle University
Dr Adam Dangoor, University Hospitals Bristol NHS Foundation Trust
Dr Debashis Sarker Guy’s and St Thomas’ NHS Foundation Trust

Welcome, introduction and agenda (Dr Alastair Greystoke)
- The evolution of biomarkers, targeted therapy and tumour agnostic therapy (Dr Alastair Greystoke)
- NTRK inhibitors (Dr Adam Dangoor)
- Case studies of NTRK inhibitors (Dr Adam Dangoor)
- NTRK gene fusions in the UK; who when and why to test (Dr Debashis Sarker)
- Faculty Q&A and meeting close (All, Dr Alastair Greystoke)
CME is not awarded for commercial symposia
Exhibition & Charity Corner
Clinical Streams – please click on the link below for the programme of preferred clinical sessions. You must view at least two clinical streams to qualify for your CME certificate and the keynote speakers. You are welcome to view all of the clinical sessions. CME points will not be awarded for commercial symposia.
Exhibition & Charity Corner
Introduction to Keynote 2 Speaker, Professor KT Patel Oxford University
Exhibition & Charity Corner
*GSK Gynae Symposium (ALL HCPs welcome)
’ Stepping through the patient journey: MDT approach to patient care in relapsed platinum sensitive ovarian cancer ’
Faculty: Chair: Marcia Hall, Helen Manderville, Jane Borley’
CME is not awarded for commercial symposia
*AstraZeneca Symposium (ALL HCPs welcome)
The evolving landscape in advanced NSCLC
This symposium will explore evolving options for the treatment and management of stage III and stage IV non-small cell lung cancer (NSCLC) patients. A key topic to be addressed during this interactive session will be prehabilitation to optimise patient fitness prior to challenging treatment regimes, with best practice examples and practical guidance on how measures can be implemented across UK centres. The symposium will also feature the latest data updates from the PACIFIC and FLAURA clinical trials, with discussions around how these may impact UK clinical practice for these heterogenous groups of patients.
CME is not awarded for commercial symposia
*Pierre Fabre CRC Symposium (ALL HCPs welcome)
A breakthrough in overall survival in BRAFV600E metastatic colorectal cancer patients
~ Welcome, introduction and session objectives (Professor Daniel Hochhauser)
~ The importance of resistance pathways within the MAPK Pathway (Professor Daniel Hochhauser)
~ What is the unmet need in BRAFV600E mutant metastatic colorectal cancer? (Professor Julien Taieb)
~ BEACON CRC data presentation (Professor Julien Taieb)
~ Speaker discussion (Professor Daniel Hochhauser and Julien Taieb)
~ Q&A and meeting close (Speakers and Audience)
CME is not awarded for commercial symposia
UK Cancer/Covid state of the nation grand discussion
Chair Professor Andrew Wardley

THE SECRETARIAT

Athena Meetings and Events is a medical events agency and secretariat, that support global cancer meetings, cancer organisations and the pharmaceutical sector to deliver seamless, high quality educational meetings. Athena are proud of their esteemed reputation within the medical meetings space and with the cancer healthcare professionals that they work with closely, across the globe.

Athena Meetings & Events provides full secretariat support to the UK Oncology Forum annual meeting.

Over 20 Years of consistently delivering excellence in client service.

Athena Meetings & Events, The Science Park Building 23, Room 23S55, Mereside, Alderley Park, Alderley Edge, Cheshire, SK10 4TG

Website: www.athenameetings.com
Contact: enquires@athenameetings.com
Telephone: +44 (0) 1625 238711